Clinical Study

Endothelial Cell Loss after Phacoemulsification according to Different Anterior Chamber Depths

Table 1

Preoperative clinical characteristics of enrolled patients.

ParameterACD IACD IIACD III
NO2NO3NO4NO2NO3NO4NO2NO3NO4

Mean age (y)68.60 ± 8.6370.93 ± 8.4669.00 ± 8.8668.73 ± 8.9071.47 ± 10.2568.27 ± 9.1871.67 ± 8.3469.27 ± 9.3570.13 ± 7.54
Mean CDVA (logMAR)0.53 ± 0.150.51 ± 0.120.56 ± 0.140.55 ± 0.170.49 ± 0.140.52 ± 0.090.51 ± 0.150.46 ± 0.100.52 ± 0.09
Mean CCT (um)538.00 ± 31.04551.73 ± 28.28561.53 ± 31.52544.13 ± 29.07543.73 ± 26.87546.13 ± 28.17540.73 ± 28.77540.60 ± 15.27552.20 ± 24.35
Mean ECC (cells/mm2)2608.13 ± 270.182658.20 ± 233.042534.53 ± 272.892700.67 ± 269.162646.27 ± 245.072532.53 ± 251.902710.73 ± 266.662602.47 ± 207.512608.53 ± 298.66
value>0.05>0.05>0.05>0.05>0.05>0.05>0.05>0.05>0.05

Means ± SD.
CDVA = corrected distance visual acuity; CCT = central corneal thickness; ECC = endothelial cell count; NO = nucleus opalescence.
Comparison of three ACD groups in the same cataract nuclear opacity subgroups (Bonferroni and Dunnett’s T3 as post hoc analysis).